Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofIdarubicin Hydrochloride for Injectionfrom Surat, Gujarat, India. Idarubicin Hydrochloride for Injection used for treatment of acute lymphoblastic leukemia and chronic myelogenous leukemia in blast crisis.
Tags: Idarubicin Hydrochloride for Injection manufacturer, Idarubicin Hydrochloridefor Injection exporter, Idarubicin Hydrochloride for Injection supplier,and Idarubicin Hydrochloride for Injection, whogmp approved Idarubicin Hydrochloridefor Injection manufacturer and supplier, Idarubicin Hydrochloride ForInjection distributor, Idarubicin Hydrochloride for Injection shipper, Idarubicin Hydrochloridefor Injection 5 ml Idarubicin Hydrochloride for Injection 5 mlsupplier,Idarubicin Hydrochloride for Injection 5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy Lifescience Idarubicin Hydrochloridefor Injection export to USA, Canada, Germany, Europe, France,Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon,Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore,Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau,Congo, Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua,Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine,Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan,Kazakhstan.
Thank You!
Thank You for your valuable time. We have received your details and will get back to you shortly.
SAINTROY LIFESCIENCE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |